All Over-The-Counter (OTC) drug products warehoused, salvaged, and sold by Inmar.

FDA Recall #D-1104-2023 — Class II — August 14, 2023

Recall #D-1104-2023 Date: August 14, 2023 Classification: Class II Status: Ongoing

Product Description

All Over-The-Counter (OTC) drug products warehoused, salvaged, and sold by Inmar.

Reason for Recall

CGMP Deviations: Potential exposure to rodents and rodent activity in the distribution center. Also, due to unusually hot weather, FDA Recalled Products may have been subjected to temperatures in excess of storage condition instructions on product labeling.

Recalling Firm

Inmar Supply Chain Solutions, LLC — Arlington, TX

Classification

Class II — May cause temporary or medically reversible adverse health consequences.

Product Type

Drugs

Product Quantity

Unknown

Distribution

Separate Distribution List (salvage buyers) provided by Inmar and will be uploaded. Final customer distribution unknown.

Code Information

Miscellaneous

Status

Ongoing

Voluntary / Mandated

N/A